- Home
- CVRX vs NRC Comparison
CVRX vs NRC Comparison
Compare CVRX & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- NRC
- Stock Information
- Founded
- CVRX 2000
- NRC 1981
- Country
- CVRX United States
- NRC United States
- Employees
- CVRX N/A
- NRC N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CVRX Health Care
- NRC Health Care
- Exchange
- CVRX Nasdaq
- NRC Nasdaq
- Market Cap
- CVRX 419.8M
- NRC 394.2M
- IPO Year
- CVRX 2021
- NRC N/A
- Fundamental
- Price
- CVRX $12.53
- NRC $12.82
- Analyst Decision
- CVRX Strong Buy
- NRC
- Analyst Count
- CVRX 7
- NRC 0
- Target Price
- CVRX $17.83
- NRC N/A
- AVG Volume (30 Days)
- CVRX 210.8K
- NRC 81.6K
- Earning Date
- CVRX 04-29-2025
- NRC 05-06-2025
- Dividend Yield
- CVRX N/A
- NRC 3.73%
- EPS Growth
- CVRX N/A
- NRC N/A
- EPS
- CVRX N/A
- NRC 1.04
- Revenue
- CVRX $51,292,000.00
- NRC $143,060,000.00
- Revenue This Year
- CVRX $27.21
- NRC N/A
- Revenue Next Year
- CVRX $25.87
- NRC N/A
- P/E Ratio
- CVRX N/A
- NRC $12.31
- Revenue Growth
- CVRX 30.53
- NRC N/A
- 52 Week Low
- CVRX $6.40
- NRC $12.32
- 52 Week High
- CVRX $19.24
- NRC $39.46
- Technical
- Relative Strength Index (RSI)
- CVRX 48.53
- NRC 31.32
- Support Level
- CVRX $11.95
- NRC $12.32
- Resistance Level
- CVRX $12.94
- NRC $15.98
- Average True Range (ATR)
- CVRX 0.57
- NRC 0.75
- MACD
- CVRX 0.16
- NRC -0.16
- Stochastic Oscillator
- CVRX 66.39
- NRC 13.66
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.